John M. Barberich
Geen lopende functies
Profiel
John M.
Barberich formerly worked at Osteologix Holdings Plc, as Chairman from 2010 to 2012, Pluromed, Inc., as Director, Scriptgen Pharmaceuticals, Inc., as Chief Financial Officer, Secretary & Treasurer, ACADIA Pharmaceuticals, Inc., as Chief Financial Officer, Secretary & Treasurer, OMRIX Biopharmaceuticals, Inc., as Chief Financial Officer, Secretary & Treasurer, Pricewaterhouse LLP, as Tax Manager, Nordic Biotech Advisors ApS, as Financial Advisor from 2004 to 2012, and Blue Note Pharmaceuticals BV, as Head-Business Development.
Mr. Barberich received his graduate degree from Georgia State University and undergraduate degree from The Pennsylvania State University.
Eerdere bekende functies van John M. Barberich
Bedrijven | Functie | Einde |
---|---|---|
Blue Note Pharmaceuticals BV
Blue Note Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Blue Note Pharmaceuticals is a privately held biopharmaceutical company with offices in Troy, New York and Amsterdam, The Netherlands. Blue Note's mission is to acquire, advance, develop, partner and commercialize carefully selected undervalued drug development candidates with the potential to more effectively treat or help prevent major medical conditions affecting society. The Company's lead development project is BNP 32,762, a pharmacokinetically unique calcium channel blocker (CCB) being evaluated in late-stage clinical trials for the treatment of hypertension and chronic stable angina. Blue Note is also evaluating various products that would combine BNP 32,762 with other commonly accepted antihypertensive drugs such as ACE inhibitors, Angiotensin Receptor Blockers (ARBs) and diuretics. The Company's cardiovascular-oriented pipeline also includes an early-stage program for the prevention of Deep Vein Thrombosis (DVT) and for the treatment of a number of other important cardiovascular indications. | Corporate Officer/Principal | 04-02-2014 |
Nordic Biotech Advisors ApS
Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | Private Equity Investor | 31-12-2012 |
OSTEOLOGIX HOLDINGS PLC | Voorzitter | 13-07-2012 |
Pricewaterhouse LLP | Corporate Officer/Principal | - |
OMRIX Biopharmaceuticals, Inc.
OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Financieel Directeur/CFO | - |
Opleiding van John M. Barberich
Georgia State University | Graduate Degree |
The Pennsylvania State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ACADIA PHARMACEUTICALS INC. | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Pluromed, Inc.
Pluromed, Inc. Medical SpecialtiesHealth Technology Pluromed, Inc. manufactures and markets disposable medical devices that are used to control bleeding during surgery. The company's trademark products include LeGoo Internal Vessel Occluder and BackStop. It was founded in 2003 and is located in Woburn, MA. | Health Technology |
Scriptgen Pharmaceuticals, Inc.
Scriptgen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Scriptgen Pharmaceuticals, Inc. discovers and develops small molecule drugs. It develops antifungal and antibacterial drugs, as well as compounds for treatment of hepatitis. The company is headquartered in Medford, MA | Health Technology |
OMRIX Biopharmaceuticals, Inc.
OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Health Technology |
Blue Note Pharmaceuticals BV
Blue Note Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Blue Note Pharmaceuticals is a privately held biopharmaceutical company with offices in Troy, New York and Amsterdam, The Netherlands. Blue Note's mission is to acquire, advance, develop, partner and commercialize carefully selected undervalued drug development candidates with the potential to more effectively treat or help prevent major medical conditions affecting society. The Company's lead development project is BNP 32,762, a pharmacokinetically unique calcium channel blocker (CCB) being evaluated in late-stage clinical trials for the treatment of hypertension and chronic stable angina. Blue Note is also evaluating various products that would combine BNP 32,762 with other commonly accepted antihypertensive drugs such as ACE inhibitors, Angiotensin Receptor Blockers (ARBs) and diuretics. The Company's cardiovascular-oriented pipeline also includes an early-stage program for the prevention of Deep Vein Thrombosis (DVT) and for the treatment of a number of other important cardiovascular indications. | Health Technology |
Osteologix Holdings Plc
Osteologix Holdings Plc Pharmaceuticals: OtherHealth Technology Osteologix Holdings Plc engaged in the development of innovative pharmaceuticals for the treatment and prevention of bone and joint tissues diseases. The company was founded in October 2004 and was headquartered in Dublin, Ireland. | Health Technology |
Pricewaterhouse LLP | Commercial Services |
Nordic Biotech Advisors ApS
Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | Finance |